Immune Response Visualized In Vivo by [18F]-FDG PET/CT after COVID-19 Vaccine.
COVID-19 vaccine
[18F]-FDG PET/CT
immune response
lymph nodes
spleen
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
09 Apr 2021
09 Apr 2021
Historique:
received:
26
03
2021
revised:
06
04
2021
accepted:
08
04
2021
entrez:
30
4
2021
pubmed:
1
5
2021
medline:
1
5
2021
Statut:
epublish
Résumé
Worldwide deployment of COVID-19 vaccines is in progress. Recent immune activation following vaccination can sometimes be seen in fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography ([18F]-FDG PET/CT). As previously evidenced, FDG-avid axillary lymph node(s) are common in patients receiving vaccines against SARS-CoV-2, influenza virus, or human papillomavirus, and reflect a regional immune response. In addition, these findings may also be accompanied by an increased spleen glucose metabolism after the COVID-19 vaccine, which captures a systemic immune response. Hence, we provide here a clinical example demonstrating that immune response could be associated with increased glucose metabolism in lymphoid organs such as lymph nodes and the spleen, which are critical modulators of T cell immunity. We believe that it is of paramount importance that nuclear physicians should be able to recognize clinical and imaging features of such immune responses upon vaccination for COVID-19 and beyond.
Identifiants
pubmed: 33918702
pii: diagnostics11040676
doi: 10.3390/diagnostics11040676
pmc: PMC8069156
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Lancet. 2021 Jan 9;397(10269):99-111
pubmed: 33306989
Eur J Nucl Med Mol Imaging. 2021 Mar 6;:
pubmed: 33675368
JACC Cardiovasc Imaging. 2015 Feb;8(2):121-30
pubmed: 25577441
Eur J Nucl Med Mol Imaging. 2009 Nov;36(11):1813-21
pubmed: 19499219
Lancet. 2021 Mar 20;397(10279):e9
pubmed: 33705696
Eur J Nucl Med Mol Imaging. 2021 May;48(5):1467-1477
pubmed: 33106925
J Nucl Med. 1999 Sep;40(9):1456-62
pubmed: 10492365
Nat Med. 2021 Mar;27(3):515-525
pubmed: 33479501
Eur J Nucl Med Mol Imaging. 2021 Feb 26;:
pubmed: 33638003